Sorry, you need to enable JavaScript to visit this website.

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.

Sign Up for AlertsDetails
Title
Grant Type
Focus Area
Country
Application Due Date
RSV Infection and RSV Maternal Immunization in Area of Obstetrics and Gynecology
Release Date:
Review Process: Pfizer Internal
Translation: Japanese (link)
Education Vaccines Japan
Local Level Educational Grants Program to Increase Awareness & Understanding of Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
Release Date:
Review Process: Pfizer Internal
Education Rare Disease USA
Real World Evidence of Abrocitinib in Adolescent Patients with Moderate-to-Severe Atopic Dermatitis
Release Date:
Review Process: Pfizer Internal
Research Inflammation & Immunology China
Education for Improvement of Early Detection and Appropriate Anticoagulant Therapy for Atrial Fibrillation
Release Date:
Review Process: Pfizer Internal
Translation: Japanese (link)
Education Internal Medicine Japan
Evolving Treatment Options in First-line Metastatic Urothelial Carcinoma (mUC) and Muscle Invasive Bladder Cancer (MIBC)
Release Date:
Partner: Astellas
Review Process: Pfizer Internal
Education Oncology All
Promoting Understanding of COVID-19 and Vaccination and Improving Communication Skills for Healthcare Professionals
Release Date:
Review Process: Expert Review Panel
Translation: Japanese (link)
Quality Improvement Vaccines Japan
American Headache Society Quality Improvement Competitive Grant Program
Release Date:
Partner: American Headache Society
Review Process: Expert Review Panel
Quality Improvement Internal Medicine USA
Boosting Oncology Opportunities for Support programs and Treatment, (BOOST), An Oncology Quality Boosting Program
Release Date:
Review Process: Expert Review Panel
Translation:(link)
Quality Improvement Oncology Netherlands
Investigator Sponsored Research for Understanding the Mechanisms and Formulating the Optimal Management of Hematological Toxicit
Release Date:
Partner: National Comprehensive Cancer Network
Review Process: Expert Review Panel
Research Oncology USA
Improving Care for Patients with Recurrent/Metastatic (R/M) Cervical Cancer
Release Date:
Review Process: Pfizer Internal
Education Oncology USA
Education on the Appropriate Diagnosis and Treatment of Overactive Bladder or Neurogenic Bladder
Release Date:
Review Process: Pfizer Internal
Translation: Japanese (link)
Education Internal Medicine Japan
Title
Grant Type
Focus Area
Country
Application Due Date
Implementation of Telemedicine in Inflammatory Conditions: A Quality Improvement RFP
Release Date:
Review Process: Pfizer Internal
Quality Improvement Inflammation & Immunology Canada, USA
ADVANCE: Global Awards for Advancing Chronic Pain Research
Release Date:
Partner: Eli Lilly and Company
Review Process: Expert Review Panel
Research Internal Medicine All
Improving Disparities in Ulcerative Colitis Health Care in Post COVID-19 Era
Release Date:
Review Process: Pfizer Internal
Quality Improvement Inflammation & Immunology United Kingdom
New Guidelines for Immuno-therapy in Urothelial Carcinoma (UC)
Release Date:
Partner: Merck KGaA Darmstadt, Germany and EMD Serono
Review Process: Pfizer Internal
Education Oncology France, Germany, Italy, Spain, USA, United Kingdom
Emerging Mechanisms of Action in the Treatment of Moderate-to-Severe Alopecia Areata
Release Date:
Review Process: Pfizer Internal
Education Inflammation & Immunology USA
PARP-inhibitor Combination Treatments in Prostate Cancer
Release Date:
Review Process: Pfizer Internal
Education Oncology All
Remote Mentoring Programs in RCC
Release Date:
Review Process: Pfizer Internal
Education Oncology USA
Quality of Care Improvement in Metastatic Breast Cancer Patients (Europe)
Release Date:
Partner: The Sharing Progress in Cancer Care (SPCC)
Review Process: Expert Review Panel
Quality Improvement Oncology All
Metastatic Breast Cancer Patient Education: Navigating Treatment & Decision Making
Release Date:
Review Process: Pfizer Internal
Education Oncology Canada, USA
NSCLC Oncogene Driver Considerations in Testing & Treatment
Release Date:
Review Process: Pfizer Internal
Education Oncology USA
Identifying and Diagnosing polyarticular Juvenile Idiopathic Arthritis (pJIA)
Release Date:
Review Process: Pfizer Internal
Education Inflammation & Immunology Canada, USA
Unmet Need and Burden of Disease in Moderate-to-Severe Alopecia Areata
Release Date:
Review Process: Pfizer Internal
Education Inflammation & Immunology France, Germany